Glick J, Oppenheim J D
Vox Sang. 1985;49(1):49-57. doi: 10.1111/j.1423-0410.1985.tb00768.x.
A method is described for the rapid purification of serologically active high titer anti-I and anti-i cold antibodies from the sera of patients with chronic cold agglutinin disease (CCAD). The purification procedure is based on thermal affinity chromatography, using desialated orosomucoid (alpha 1-acid glycoprotein)-Sepharose 4B conjugated beads. The nature of the interaction between the cold agglutinins (CA) and the desialated orosomucoid is unknown. Inhibition studies, however, revealed that the cold hemagglutinating activities of all the anti-i sera were inhibited by desialated orosomucoid while only 1 out of 4 of the anti-I sera was similarly affected. Anti-I or anti-i antibodies were separated from whole sera in 7 out of 7 samples with a recovery in most cases of 100% of the cold hemagglutinating activity. The resultant products were purified monoclonal IgM fractions which could react with anti-kappa and anti-mu but not with anti-lambda sera. The homogeneity, purity and specificity of all preparations were confirmed by immunodiffusion analysis against purified I and i blood group antigens isolated from human erythrocyte membranes, zonal and right-angle electrophoresis and hemagglutination or hemagglutination inhibition studies.
本文描述了一种从慢性冷凝集素病(CCAD)患者血清中快速纯化具有血清学活性的高滴度抗-I和抗-i冷凝集素的方法。纯化过程基于热亲和色谱法,使用去唾液酸正铁蛋白(α1-酸性糖蛋白)-琼脂糖4B偶联珠。冷凝集素(CA)与去唾液酸正铁蛋白之间相互作用的性质尚不清楚。然而,抑制研究表明,所有抗-i血清的冷凝集活性均被去唾液酸正铁蛋白抑制,而4份抗-I血清中只有1份受到类似影响。在7个样本中的7个样本中,抗-I或抗-i抗体从全血清中分离出来,大多数情况下冷凝集活性的回收率为100%。所得产物为纯化的单克隆IgM组分,可与抗κ和抗μ反应,但不与抗λ血清反应。通过针对从人红细胞膜分离的纯化I和i血型抗原的免疫扩散分析、区带电泳和直角电泳以及血凝或血凝抑制研究,证实了所有制剂的同质性、纯度和特异性。